<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01102153</url>
  </required_header>
  <id_info>
    <org_study_id>COOL-NSE</org_study_id>
    <nct_id>NCT01102153</nct_id>
  </id_info>
  <brief_title>Neuron Specific Enolase (NSE) as Outcome Parameter of Cooling Therapy After Survived Sudden Cardiac Death</brief_title>
  <official_title>NSE as an Outcome Predictor of Therapeutical Hypothermia After Survived Sudden Cardiac Death</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sudden cardiac death remains one of the major leading causes of death. Therapeutic
      hypothermia is a validated standard procedure to avoid or minimize cognitive deficits after
      cardiac arrest. To assess the efficiency of different cooling methods and further improve
      these methods, the investigators collected blood samples to measure the neuron specific
      enolase (NSE) in patients treated with invasive cooling as compared to patients treated with
      non-invasive cooling.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Consecutive patients with restoration of spontaneous circulation after resuscitation due to
      sudden cardiac death were randomized to either non-invasive or invasive cooling for at least
      24 hours. NSE was collected at designated time points and compared between patients treated
      with invasive cooling and those treated with non-invasive cooling. Neurological outcome was
      assessed between groups at hospital discharge and 6 months after discharge.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>neuron specific enolase (NSE) as a parameter for cerebral damage</measure>
    <time_frame>72 hours</time_frame>
    <description>Blood samples were collected at predefined time-points within 72 hours to measure neuron specific enolase.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>neurologic outcome</measure>
    <time_frame>6 months</time_frame>
    <description>At 6 months after cardiac arrest, the cerebral performance category score is assessed to determine neurologic outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to overall survival</measure>
    <time_frame>one year</time_frame>
    <description>At one year after cardiac arrest, overall survival of the cardiac arrest patients is assessed.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">108</enrollment>
  <condition>Cardiac Arrest</condition>
  <condition>Hypothermia</condition>
  <arm_group>
    <arm_group_label>Coolgard</arm_group_label>
    <description>invasive cooling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ArcticSun</arm_group_label>
    <description>non-invasive (surface) cooling</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coolgard</intervention_name>
    <description>invasive cooling via femoral ICY-catheter</description>
    <arm_group_label>Coolgard</arm_group_label>
    <other_name>CG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ArcticSun</intervention_name>
    <description>non-invasive surface cooling by saline-cooled thermo-vest</description>
    <arm_group_label>ArcticSun</arm_group_label>
    <other_name>AS</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who survived sudden cardiac arrest and where treated with cooling-therapies
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ROSC after sudden cardiac death (SCA) due to VF/VT or PEA/Asystolia

          -  GCS 3

        Exclusion Criteria:

          -  Non-cardiac sudden death

          -  Pregnancy

          -  Unstable circulation with high-dose inotropics

          -  Life-expectancy reducing concomitant illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Holger Thiele, Associate Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Study Chair</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Undine Pittl, MD</last_name>
    <role>Study Director</role>
    <affiliation>Study Sub-Investigator</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexandra Schratter, MD</last_name>
    <role>Study Director</role>
    <affiliation>Study Sub-Investigator</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Leipzig, Heart Center, Cardiology</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Leipzig, Heart Center, Cardiology</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Sulaj M, Saniova B, Drobna E, Schudichova J. Serum neuron specific enolase and malondialdehyde in patients after out-of-hospital cardiac arrest. Cell Mol Neurobiol. 2009 Sep;29(6-7):807-10. doi: 10.1007/s10571-009-9361-y. Epub 2009 Feb 25.</citation>
    <PMID>19241153</PMID>
  </reference>
  <reference>
    <citation>Shinozaki K, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Abe R, Tateishi Y, Hattori N, Shimada T, Hirasawa H. S-100B and neuron-specific enolase as predictors of neurological outcome in patients after cardiac arrest and return of spontaneous circulation: a systematic review. Crit Care. 2009;13(4):R121. doi: 10.1186/cc7973. Epub 2009 Jul 22. Review.</citation>
    <PMID>19624826</PMID>
  </reference>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2010</study_first_submitted>
  <study_first_submitted_qc>April 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 13, 2010</study_first_posted>
  <last_update_submitted>April 12, 2010</last_update_submitted>
  <last_update_submitted_qc>April 12, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 13, 2010</last_update_posted>
  <responsible_party>
    <name_title>Holger Thiele, Assistant Professor</name_title>
    <organization>University of Leipzig, Heart Center</organization>
  </responsible_party>
  <keyword>sudden cardiac arrest</keyword>
  <keyword>Hypothermia</keyword>
  <keyword>Coolgard</keyword>
  <keyword>arctic sun</keyword>
  <keyword>neurological outcome</keyword>
  <keyword>neuron specific enolase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Hypothermia</mesh_term>
    <mesh_term>Death</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

